Effects of exposure to amphetamine derivatives on passive avoidance performance and the central levels of monoamines and their metabolites in mice: Correlations between behavior and neurochemistry
- 13 October 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Psychopharmacology
- Vol. 220 (3), 495-508
- https://doi.org/10.1007/s00213-011-2504-0
Abstract
Rationale Considerable evidence indicates that amphetamine derivatives can deplete brain monoaminergic neurotransmitters. However, the behavioral and cognitive consequences of neurochemical depletions induced by amphetamines are not well established. Objectives In this study, mice were exposed to dosing regimens of 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine (METH), or parachloroamphetamine (PCA) known to deplete the monoamine neurotransmitters dopamine and serotonin, and the effects of these dosing regimens on learning and memory were assessed. Methods In the same animals, we determined deficits in learning and memory via passive avoidance (PA) behavior and changes in tissue content of monoamine neurotransmitters and their primary metabolites in the striatum, frontal cortex, cingulate, hippocampus, and amygdala via ex vivo high-pressure liquid chromatography. Results Exposure to METH and PCA impaired PA performance and resulted in significant depletions of dopamine, serotonin, and their metabolites in several brain regions. Multiple linear regression analysis revealed that the tissue concentration of dopamine in the anterior striatum was the strongest predictor of PA performance, with an additional significant contribution by the tissue concentration of the serotonin metabolite 5-hydroxyindoleacetic acid in the cingulate. In contrast to the effects of METH and PCA, exposure to MDMA did not deplete anterior striatal dopamine levels or cingulate levels of 5-hydroxyindoleacetic acid, and it did not impair PA performance. Conclusions These studies demonstrate that certain amphetamines impair PA performance in mice and that these impairments may be attributable to specific neurochemical depletions.This publication has 51 references indexed in Scilit:
- Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in miceNeuroscience Research, 2009
- A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouseNeuroscience, 2008
- The Effect of Catecholamine Depletion by Alpha-Methyl-Para-Tyrosine on Measures of Cognitive Performance and Sleep in Abstinent MDMA UsersNeuropsychopharmacology, 2007
- Impairment in Consolidation of Learned Place Preference Following Dopaminergic Neurotoxicity in Mice is Ameliorated by N-acetylcysteine but not D1 and D2 Dopamine Receptor AgonistsNeuropsychopharmacology, 2006
- Behavioural changes in rats treated with a neurotoxic dose regimen of dextrorotatory amphetamine derivativesBehavioural Pharmacology, 2003
- Long-term effects of ‘ecstasy’ abuse on the human brain studied by FDG PETNuclear Medicine Communications, 2001
- Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicalsBrain Research, 1995
- MDMA: Historical PerspectivesAnnals of the New York Academy of Sciences, 1990
- Biological Disposition of Rigid Analogs of AmphetamineJournal of Pharmaceutical Sciences, 1977
- Decrease of cerebral 5-hydroxytryptamine and 5-hydroxyindolacetic acid by an arylalkylamineLife Sciences, 1963